Navigation Links
Watson Pharmaceuticals Reports Second Quarter 2008 Results
Date:8/6/2008

81

Selling and marketing 13,825 13,197 27,878 27,746

Segment contribution $106,112 $98,134 $206,495 $209,074

Segment margin 28.2% 28.4% 27.8% 27.1%

Generic product sales for the second quarter of 2008 increased $16.8 million to $344.3 million, reflecting the addition of new products which were offset in part by price erosion in the base business.

Generic other revenue increased $14.2 million to $32.4 million. Generic other revenue includes a $15 million sales milestone from Barr Pharmaceuticals, Inc. following a 1999 legal settlement, and reflects the addition of royalties from Sandoz's sales of metoprolol succinate extended-release tablets 50mg.

Generic gross profit was $149.1 million in the second quarter of 2008, compared to $135.3 million in the second quarter of 2007 and $137.0 million in the first quarter 2008. Generic gross profit for the second quarter 2008 reflects the sales milestone and approximately $4.5 million in costs related to Watson's Global Supply Chain Initiative. Excluding these items, Generic gross profit was $138.5 million, or 38.3 percent of revenue in the second quarter 2008.

Generic research and development expense increased 22 percent or $5.2 million to $29.1 million. Watson currently has approximately 60 ANDAs on file with the FDA.

Brand Segment Information

Three Months Ended Six Months Ended

June 30, June 30,

(Unaudited; $ in thousands) 2008 2007 2008 2007

Brand Segment Contribution

Product sales $101,466 $96,924 $200,458 $187,562

Other revenue 16,535 13,809 32,834 24,711

Net revenue 118,001 110,733 233,292 212,273

Cost of sales 24,
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Watson Receives FDA Approval for Generic Accuneb(R)
3. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
4. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
5. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
6. Barr Subsidiary Sues Watson for SEASONIQUE(R) Patent Infringement
7. Watson Files FDA Application for Generic LYBREL(R)
8. FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceuticals TRELSTAR(R) DEPOT and TRELSTAR(R) LA
9. Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
10. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
11. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 On Friday, December 19, ... the Omnibus and Continuing Resolution Appropriations Act of ... a condition eligible to receive funding through the ... the Department of Defense (DoD). The Hydrocephalus Association ... Capitol Hill, is celebrating this victory for the ...
(Date:12/24/2014)... December 23, 2014 Pipette.com announces their ... Twitter followers can submit their #HolidayInTheLab pictures for a ... lab mates. , For those struggling to think of ... Pipette.com Holiday in the Lab Contest provides the ideal ... followers to send pictures of their chemistree, holiday ...
(Date:12/24/2014)... SARASOTA, Fla. , Dec. 23, 2014  Rock ... today that it has filed a Clinical Trial Application ... Medicines Healthcare products Regulatory Agency (MHRA) seeking regulatory approval ... its lead molecule, Anatabine Citrate. Contingent on ... to conduct a Phase I trial to assess the ...
(Date:12/22/2014)... Dec. 22, 2014  Alternative Energy & Environmental ... has signed a letter of intent to acquire ... and patented a nanotechnology-based development platform used to ... enable rapid on-site collection and testing to identify ... issues in an immediate, non-invasive and cost-effective manner. ...
Breaking Biology Technology:Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3ALNE Announces Intention To Acquire BioTechPharma 2
... 27 Warner Chilcott Limited (Nasdaq: WCRX ... Inc. has submitted a New Drug Application for WC ... and Drug Administration. About Warner Chilcott ... currently focused on the women,s healthcare and dermatology segments ...
... Record and A Year,s Supply of Breathalicious ... Sweet at the White HouseLOS ANGELES, March ... Bulletin Board: FVRL), which through its wholly-owned ... consumer-controlled Personal Health Records ("PHRs") ( www.mymedicalrecords.com ...
... to stockholders through liquidationA decisive victory for stockholder ... L.P. ("BVF"), today announced that stockholders of Avigen ... remove the existing Board of Directors of Avigen ... took place earlier today at the special meeting ...
Cached Biology Technology:Warner Chilcott Announces NDA Submission for Low Dose Oral Contraceptive 2Warner Chilcott Announces NDA Submission for Low Dose Oral Contraceptive 3MMR and Dancing Paws to Participate in Joint Sales Effort to Provide Personal Health Records for Pets 2MMR and Dancing Paws to Participate in Joint Sales Effort to Provide Personal Health Records for Pets 3MMR and Dancing Paws to Participate in Joint Sales Effort to Provide Personal Health Records for Pets 4Biotechnology Value Fund, L.P. Announces Overwhelming Support to Remove the Board of Directors of Avigen, Inc. at Special Meeting of Stockholders 2
(Date:12/10/2014)... , Dec. 8, 2014 You,ve been here before: ... but can,t remember your password, site key or the answer ... your first grade teacher? Today, Hoyos ... app that will finally put an end to the ... 1U TM . 1U leverages a user,s smartphone to ...
(Date:12/10/2014)... , Dec. 9, 2014 CIE San Diego ... that provides the connective tissue that enhances care coordination ... to easily share client-level information; earned a second $1 ... to organizations serving seniors aging in community and; will ... on December 11 th 4-6p. CIE ...
(Date:12/5/2014)... VIEW, Calif. , Dec. 4, 2014 /PRNewswire/ ... safety has boosted investments in new testing and ... has also given rise to a range of ... by the requirements of Generation Y, which is ... technologies. As a result, product development strategies of ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... In an effort to make data storage more cost-effective, ... Taiwan and the Karlsruhe Institute of Technology in Germany have ... that uses ultraviolet (UV) light to make it possible to ... the AIP,s Applied Physics Letters , consists of a ...
... assistant professor on the Florida campus of The Scripps ... grants to study a critical component of long-term memory ... years from the prestigious Whitehall Foundation to study the ... kinesin. In this study, he will use the marine ...
... SAN DIEGO -- Lung cancer is the most commonly diagnosed ... unless caught early, but scientists are working on ways to ... of scientists will gather in San Diego at the San ... the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: ...
Cached Biology News:Scripps Research Scientist wins pair of grants to study critical component of memory 2Lung cancer conference to focus on new diagnostic techniques, potential treatments 2
... Varians unique collision reaction interface (CRI) ... of troublesome spectroscopic interferences. The result ... without the worry of complex multipole ... cells. And, by coupling autotuning of ...
a1-Antitrypsin (human, alpha-1 AT)...
... Microsomal vesicles are used to study ... proteins. Processing events such as signal ... core glycosylation can be examined by ... in vitro in the presence of ...
... Bio luciferase assay. Mo Bio Laboratories offers the ... you to certify your products ATP-Free with a ... deliver them to your customers in a timely ... 3.5 x 10-12 /l, which will allow you ...
Biology Products: